|
 |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
Obesity drug market to reach $600 mn by 2018
 |
|
| According to the forecast of independent business analyst, the anti-diabetics market will be worth $37 billion by 2018 up from $20 billion in 2008. This rapid market expansion presents significant opportunities for pharmaceutical companies that are a |
|
 |
|
|
| |
|
|
| |
|
|
| |
| Abbott acquires Facet Biotech for $450 mn
|
|
| Abbott is buying Facet Biotech for $450 million enhancing its early- and mid-stage pharmaceutical pipeline. The acquisition brings access to biologics in two key therapeutic areas, immunology and oncology |
|
|
|
|
| |
|
|
| More |
